Alcohol, marijuana, and tobacco are substances most commonly used by adolescents. Substance use in adolescence becomes risky, when does substance use become substance abuse? This presentation will focus on adolescent substance use and abuse. This presentation will also focus on the most commonly abused substances during adolescence, factors that contribute to substance abuse and treatment plans. | 1.50 credits (1.50 pharmacology) | $40

The ‘tridemic’ is threatening to overwhelm healthcare systems throughout the United States. This presentation will focus on the impact of the ‘tridemic’ and the management of common pediatric disorders. Discussion will include differential diagnosis, treatment strategies and medication management of common pediatric disorders. | 1.50 credits (1.50 pharmacology) | $40

The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. | 1 credits (0.75 pharmacology) | $30

The presentation provides practitioners with several unique concepts in preparing their patients for travel, including both land and sea destinations. | 1.50 credits (1.50 pharmacology) | $40

PAH is a very difficult illness to identify and treat. It is often missed by the most skilled clinician. This session will discuss a brief overview of the diagnosis then dive into best treatment options. The treatments options are many and very diverse, coming with costly side effects and high cost overall. This session will discuss when to treat, how soon to treat and when NOT to treat. | 1.50 credits (1.50 pharmacology) | $40

A brief overview of Allergic Asthma and when to apply the newest treatment options. The need to treat aggressively will be a focus as to avoid “remodeling” of the lungs. Using the “Step wise” approach to treatment with a few updates will help the practicing clinician decide what treatments are the best and when to initiate. Time is of the essence with a pulmonary patient and aggressive treatment and management will be the focus of this session. | 1.50 credits (1.50 pharmacology) | $40

The predominance of both Type 1 and Type 2 diabetes across the lifespan necessitate the primary care clinicians knowledge of when to start and how to manage insulin. This presentation will review pathophysiology of diabetes as a disease as well as differentials to consider when medication management fails. A review will be presented of diagnostic criteria to guide starting and dosage, choice of insulin, subjective and objective data to foster adjustment, barriers to insulin management in both patients and clinicians, and markers of success. | 1.50 credits (1.50 pharmacology) | $40

Heart failure (HF) affects millions of people and is associated with substantial high morbidity and mortality, as well as high rates of hospitalization. Therefore, it is essential for practitioners to be able to diagnose and manage these individuals. Subsets of HF including HFpEF (preserved ejection fraction) and HFrEF (reduced ejection fraction) are commonly encountered in clinical practice. This session will focus on the recognition, treatment and prevention of HF, along with discussion of current guidelines that will assist practitioners to effectively manage these patients. | 1.50 credits (0.75 pharmacology) | $40

Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options. | 1.50 credits (0.75 pharmacology) | $40

As a result of the opioid crisis, no medical profession has come under more scrutiny, regulatory oversight, and increased legal risk than primary care providers who prescribe opioids. This course will cover DEA’s authority, an overview of current drugs of concerns and emerging drug threats, medical provider and office controlled substance risks along with case studies followed by various drug updates including fentanyl, CBD, Kratom, medication assisted treatment, drug destruction, telemedicine, DEA FAQ’s, DEA provider resources and overall provider risk mitigations safeguards. This isn’t a “theory class” from an attorney who’s never been in the courtroom or one about “recent case rulings” on one about “drug policy analysis”, but a hands-on, data driven, common sense review of problem areas from a former DEA agent with real life opioid experience. | 1.50 credits (1.0 pharmacology) | $40